Cinctive Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $681K | Sell |
|
|||||
|
2025
Q1 | $2.8M | Buy |
|
|||||
|
2024
Q4 | $2.65M | Buy |
|
|||||
|
2024
Q3 | $883K | Sell |
|
|||||
|
2024
Q2 | $5.21M | Buy |
|
|||||
|
2024
Q1 | $5.22M | Buy |
|
|||||
|
2023
Q4 | $4.69M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $6.51M | Buy |
|
|||||
|
2021
Q4 | $6.2M | Buy |
|
|||||
|
2021
Q3 | $5.31M | Buy |
|
|||||
|
2021
Q2 | $2.74M | Buy |
|
|||||
|
2021
Q1 | $1.7M | Buy |
|
|||||
|
2020
Q4 | $823K | Sell |
|
|||||
|
2020
Q3 | $2.8M | Sell |
|
|||||
|
2020
Q2 | $2.98M | Sell |
|
|||||
|
2020
Q1 | $2.67M | Sell |
|
|||||
|
2019
Q4 | $5.71M | Buy |
|